Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2002
02/21/2002CA2418365A1 Methods for blocking resistance to bt toxins in insects and nematodes
02/21/2002CA2418320A1 The anti-neoplastic agent et-743 inhibits trans activation by sxr
02/21/2002CA2418317A1 Bacillus transformation, transformants and mutant libraries
02/21/2002CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
02/21/2002CA2418266A1 Novel mitogen activated kinase
02/21/2002CA2418087A1 Use of microbial dna sequences for the identification of human diseases
02/21/2002CA2417986A1 Single-labeled oligonucleotide probes
02/21/2002CA2417152A1 Therapeutic compounds for ovarian cancer
02/21/2002CA2417141A1 Novel glycoproteins and methods of use thereof
02/21/2002CA2416898A1 Method and composition for altering a b cell mediated pathology
02/21/2002CA2416794A1 Method and composition for altering a t cell mediated pathology
02/20/2002EP1180686A1 Remedies for kidney diseases and method for screening the same
02/20/2002EP1180684A1 High estrogen-sensitive medaka fish
02/20/2002EP1180525A1 Transcriptional activation inhibitory protein
02/20/2002EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
02/20/2002EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
02/20/2002EP1180238A1 Device and method for isolating electrically charged molecules
02/20/2002EP1180169A1 Methods of detecting polynucleotide kinase and its use as a label
02/20/2002EP1180167A1 In vivo selection method for determining inhibitory rna molecules
02/20/2002EP1180164A2 Methods using of fab i and compounds modulating fab i activity
02/20/2002EP1180160A1 Antibiotic-based gene regulation system
02/20/2002EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders
02/20/2002EP1180158A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
02/20/2002EP1180157A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
02/20/2002EP1180156A1 Methods for induction of tolerance to adenoviral vectors and transgene products
02/20/2002EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes
02/20/2002EP1180154A1 PROMOTER OF THIOREDOXINE TaTrxh2 IN WHEAT
02/20/2002EP1180153A1 Phage-dependent super-production of biologically active proteins and peptides
02/20/2002EP1180152A1 Recombinant bacterial phytases and uses thereof
02/20/2002EP1180151A2 Protein kinases
02/20/2002EP1180150A2 Nucleic acid immunization
02/20/2002EP1180149A2 Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants
02/20/2002EP1180148A1 A VARIANT OF C6 BETA-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
02/20/2002EP1180147A1 Secreted alpha-helical protein-31
02/20/2002EP1180146A1 Secreted alpha-helical protein - 32
02/20/2002EP1180145A1 Biosynthesis of foreign proteins using transformed microalgae
02/20/2002EP1180144A2 Cytoskeleton-associated proteins
02/20/2002EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
02/20/2002EP1180142A2 Methods and compositions for measuring ion channel conductance
02/20/2002EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof
02/20/2002EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway
02/20/2002EP1180139A1 Trehalose synthase protein, gene, plasmids, microorganisms, and a process for producing trehalose
02/20/2002EP1180138A1 A polynucleotide motor, a motor system, their preparation and uses
02/20/2002EP1180123A1 Immunoconjugates having high binding affinity
02/20/2002EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors
02/20/2002EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
02/20/2002EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS
02/20/2002EP1180118A1 Fimbrial proteins
02/20/2002EP1180117A1 Models of prion disease
02/20/2002EP1180113A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
02/20/2002EP1180112A1 Detection using degradation of a tagged sequence
02/20/2002EP1180040A2 Methods for treating congestive heart failure
02/20/2002EP1180039A2 Factor for regulation of neurite growth
02/20/2002EP1180016A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
02/20/2002EP1056528A4 Method for high resolution liquid chromatographic separation of polynucleotides
02/20/2002EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection
02/20/2002EP0749485B1 Antimicrobial proteins from impatiens
02/20/2002EP0667904B1 Suppressor and progenitor cells
02/20/2002CN1336960A DNA sequencing method which employs various DNA polymerases and kit used for the same
02/20/2002CN1336959A Method for introducing substances into cells and use of said method
02/20/2002CN1336958A Pyruvate carboxylase from i(Corynebacterium glutamicum)
02/20/2002CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis
02/20/2002CN1336935A Compositions and methods for WT1 specific immunotherapy
02/20/2002CN1336796A Method of constructing male sterile plant
02/20/2002CN1336436A Method of improving soluble expression of foreign gene in colon bacillus
02/20/2002CN1336435A Construction technology of recombinant insect cross virus expression vector
02/20/2002CN1336432A Production process and biological activity of recombinant exarid kinase
02/20/2002CN1336431A Establishment of immortal human ovary carcinoma cell strain
02/20/2002CN1336382A Endothelial cell growth resisting engineered protein
02/20/2002CN1336381A Trichosanthin mutant and its prepn.
02/20/2002CN1336158A Dynamic observation method of tumor and angiogenesis
02/20/2002CN1079433C Prodn. of fibrinogen in transgenic animals
02/20/2002CN1079430C High-pressure gas gene gun
02/19/2002US6348643 For transgenic plants with improved herbicide resistance especially for imidazolinone herbicides
02/19/2002US6348642 Transformed plants and plant cells for altered fatty acid biosynthesis
02/19/2002US6348641 Purified proteins, recombinant DNA sequences and processes for producing caffeine-free beverages
02/19/2002US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes
02/19/2002US6348585 Amino acid sequence; treatment and diagnosis of cardiovascular, nervous system, and psychological disorders; antiulcer agents; hypotensive/hypertensive agents
02/19/2002US6348584 Fibronectin binding protein compounds
02/19/2002US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics
02/19/2002US6348582 Prokaryotic polynucleotides polypeptides and their uses
02/19/2002US6348580 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
02/19/2002US6348579 FtsL
02/19/2002US6348578 Apt
02/19/2002US6348577 Regulation of aureobasidin sensitivity in fungus
02/19/2002US6348576 Human cornichon molecule
02/19/2002US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis
02/19/2002US6348569 Spruce budworm antifreeze proteins, genes and method of using same
02/19/2002US6348499 Amphiphilic polyamide compounds
02/19/2002US6348486 Methods for modulating bladder function
02/19/2002US6348449 Methods of inducing mucosal immunity
02/19/2002US6348353 Artificial mammalian chromosome
02/19/2002US6348352 Purging tumor cells from a hematopoietic progenitor cell population by introducing a stable tumor suppressor gene into a heterogeneous cell population and selectively transducing phenotypically hyperproliferative cells
02/19/2002US6348351 Tie receptor tyrosine kinase ligand homologues
02/19/2002US6348350 A nucleic acid that codes a mammalian native ligand tyrosine kinase containing an immunoglobulin and an epidermal growth factor domain; that induces vasculariation; diagnosis and therapy for promoting or inhibiting neovascularization
02/19/2002US6348349 A rodent embryonic stem cell transformed with yeast artifical chromosomes, with introducing yeast dna; for efficient transformations
02/19/2002US6348344 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
02/19/2002US6348343 Human DNase I variants
02/19/2002US6348342 Compounds
02/19/2002US6348340 Compounds